{"id":"https://openalex.org/W2268314510","doi":null,"title":"Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.","display_name":"Molecular advances in pretargeting radioimunotherapy with bispecific antibodies.","publication_year":2002,"publication_date":"2002-05-01","ids":{"openalex":"https://openalex.org/W2268314510","mag":"2268314510","pmid":"https://pubmed.ncbi.nlm.nih.gov/12479274"},"language":"en","primary_location":{"id":"pmid:12479274","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12479274","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109346302","display_name":"Chien\u2010Hsing Chang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Chien-Hsing Chang","raw_affiliation_strings":["IBC Pharmaceuticals, L. L. C., Morris Plains, New Jersey 07950, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IBC Pharmaceuticals, L. L. C., Morris Plains, New Jersey 07950, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043569662","display_name":"Robert M. Sharkey","orcid":"https://orcid.org/0000-0003-1408-0905","observed_orcids":["https://orcid.org/0000-0003-1408-0905"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert M Sharkey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110966471","display_name":"Edmund A. Rossi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edmund A Rossi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045775470","display_name":"Habibe Karacay","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Habibe Karacay","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"William McBride","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William McBride","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111565592","display_name":"Hans J. Hansen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hans J Hansen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111629101","display_name":"Jean\u2010Fran\u00e7ois Chatal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jean-Fran\u00e7ois Chatal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004255429","display_name":"Jacques Barbet","orcid":"https://orcid.org/0000-0002-9188-984X","observed_orcids":["https://orcid.org/0000-0002-9188-984X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jacques Barbet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5003890903","display_name":"David M. Goldenberg","orcid":"https://orcid.org/0000-0001-5539-421X","observed_orcids":["https://orcid.org/0000-0001-5539-421X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David M Goldenberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":12.2819,"has_fulltext":false,"cited_by_count":129,"citation_normalized_percentile":{"value":0.99133296,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"1","issue":"7","first_page":"553","last_page":"63"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pretargeting","display_name":"pretargeting","score":0.8859999775886536},{"id":"https://openalex.org/keywords/radioimmunotherapy","display_name":"radioimmunotherapy","score":0.949999988079071},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":1.0},{"id":"https://openalex.org/keywords/radionuclide-delivery","display_name":"radionuclide delivery","score":0.878000020980835},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.6240000128746033},{"id":"https://openalex.org/keywords/tumor-to-nontumor-ratio","display_name":"tumor-to-nontumor ratio","score":0.828000009059906},{"id":"https://openalex.org/keywords/antibody-clearance","display_name":"antibody clearance","score":0.5410000085830688},{"id":"https://openalex.org/keywords/peptide-carriers","display_name":"peptide carriers","score":0.3059999942779541}],"concepts":[{"id":"https://openalex.org/C2777836882","wikidata":"https://www.wikidata.org/wiki/Q22907915","display_name":"Pretargeting","level":5,"score":0.9971407651901245},{"id":"https://openalex.org/C2776146153","wikidata":"https://www.wikidata.org/wiki/Q7281276","display_name":"Radioimmunotherapy","level":4,"score":0.7268116474151611},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.5617604851722717},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5434889793395996},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5115712285041809},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4710053503513336},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.45914149284362793},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.43315377831459045},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.3794527053833008},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3353145122528076},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15754258632659912}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006241","descriptor_name":"Haptens","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011874","descriptor_name":"Radiometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016499","descriptor_name":"Radioimmunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:12479274","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12479274","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"mag:2268314510","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12479274","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1554469355","display_name":"Improved Detection of Cancer Using Bi Specific Antibody","funder_award_id":"1r01ca084379-01a2","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":60,"referenced_works":["https://openalex.org/W139055546","https://openalex.org/W190158683","https://openalex.org/W1486518489","https://openalex.org/W1512221515","https://openalex.org/W1530755505","https://openalex.org/W1535266283","https://openalex.org/W1559715985","https://openalex.org/W1573430780","https://openalex.org/W1761835237","https://openalex.org/W1822661802","https://openalex.org/W1833143896","https://openalex.org/W1848594274","https://openalex.org/W1926518917","https://openalex.org/W1952970584","https://openalex.org/W1964474031","https://openalex.org/W1971652464","https://openalex.org/W1982058902","https://openalex.org/W1982212192","https://openalex.org/W1986508172","https://openalex.org/W1990453110","https://openalex.org/W2001885738","https://openalex.org/W2002934363","https://openalex.org/W2004112687","https://openalex.org/W2004224153","https://openalex.org/W2011224892","https://openalex.org/W2015199454","https://openalex.org/W2026305248","https://openalex.org/W2029445411","https://openalex.org/W2035755158","https://openalex.org/W2042864380","https://openalex.org/W2048256052","https://openalex.org/W2053694429","https://openalex.org/W2058970445","https://openalex.org/W2063763866","https://openalex.org/W2064082799","https://openalex.org/W2070924103","https://openalex.org/W2076953141","https://openalex.org/W2090503393","https://openalex.org/W2091016562","https://openalex.org/W2116671252","https://openalex.org/W2125814580","https://openalex.org/W2165045635","https://openalex.org/W2169072424","https://openalex.org/W2171019334","https://openalex.org/W2181842957","https://openalex.org/W2183875932","https://openalex.org/W2184839900","https://openalex.org/W2200499915","https://openalex.org/W2222777425","https://openalex.org/W2287865666","https://openalex.org/W2410029684","https://openalex.org/W2411059694","https://openalex.org/W2411175330","https://openalex.org/W2414712300","https://openalex.org/W2415473575","https://openalex.org/W2460081145","https://openalex.org/W2472614799","https://openalex.org/W2474147406","https://openalex.org/W2496831027","https://openalex.org/W2798330367"],"related_works":["https://openalex.org/W2070512434","https://openalex.org/W2015825998","https://openalex.org/W2101240256","https://openalex.org/W116848897","https://openalex.org/W2138209595","https://openalex.org/W2079848397","https://openalex.org/W1970142997","https://openalex.org/W2184100701","https://openalex.org/W2021396643","https://openalex.org/W2003569476"],"abstract_inverted_index":{"The":[0],"use":[1],"of":[2,13,32,53,61,78,83,86,98,113,138,157,190],"antibodies":[3,28,151],"against":[4],"tumor-associated":[5],"cell":[6],"surface":[7],"antigens":[8],"for":[9,39,152,161],"the":[10,30,64,76,87,90,94,114,129,136,143,182],"targeted":[11],"delivery":[12,52,112],"radionuclides":[14,54],"was":[15,140],"introduced":[16],">20":[17],"years":[18],"ago.":[19],"Although":[20],"encouraging":[21],"results":[22,174],"have":[23],"been":[24,56],"achieved":[25],"with":[26,44,145],"radiolabeled":[27],"in":[29,67,142],"management":[31],"hematopoietic":[33],"malignancies,":[34],"there":[35],"remains":[36],"a":[37,106,119,124,177],"need":[38],"successfully":[40],"treating":[41],"solid":[42],"tumors":[43],"this":[45],"modality.":[46],"One":[47],"promising":[48],"approach":[49],"involving":[50],"pretargeted":[51],"has":[55],"shown":[57],"to":[58,70,103],"be":[59],"capable":[60],"significantly":[62],"increasing":[63],"radioactive":[65,115],"uptake":[66],"tumor":[68],"relative":[69],"normal":[71],"organs,":[72],"thereby":[73],"potentially":[74],"improving":[75],"efficacy":[77],"both":[79,170],"detection":[80],"and":[81,101,109,132,172],"therapy":[82],"cancer.":[84],"Uncoupling":[85],"radionuclide":[88],"from":[89,176],"tumor-targeting":[91],"antibody":[92,99],"allows":[93],"relatively":[95],"slow":[96],"process":[97],"localization":[100],"clearance":[102],"occur":[104],"before":[105],"very":[107],"rapid":[108],"highly":[110],"specific":[111],"payload":[116],"carried":[117],"on":[118,147],"small":[120],"molecule,":[121],"such":[122],"as":[123,181],"peptide.":[125],"This":[126],"minireview":[127],"discusses":[128],"various":[130],"strategies":[131],"advancements":[133],"made":[134],"since":[135],"concept":[137],"pretargeting":[139,159,178,191],"proposed":[141],"mid-1980s,":[144],"emphasis":[146],"those":[148],"comprising":[149],"bispecific":[150],"cancer":[153],"therapy.":[154],"Critical":[155],"aspects":[156],"these":[158],"systems":[160],"achieving":[162],"higher":[163],"tumor:nontumor":[164],"ratios":[165],"are":[166,186,193],"considered.":[167],"In":[168],"addition,":[169],"preclinical":[171],"clinical":[173],"obtained":[175],"method":[179],"known":[180],"Affinity":[183],"Enhancement":[184],"System":[185],"presented.":[187],"Future":[188],"directions":[189],"technology":[192],"also":[194],"suggested.":[195]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}